FindMyKOL

Top experts by indication / Oncology

Most active experts in Sarcoma

2026 edition, data as of October 26, 2026

479 key opinion leaders in the directory are tagged to Sarcoma. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.

Most registered trials

Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 383 of the 479 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.

#Experttrials
1Seth PollackNorthwestern University Feinberg School of Medicine, IL12 trials
2Robert MakiPA11 trials
3Aerang KimMD9 trials
4William TapMemorial Sloan Kettering Cancer Center, NY9 trials
5Patrick WenDana-Farber Cancer Institute8 trials
6Scott SchuetzeUniversity of Michigan, MI8 trials
7Martee HensleyMemorial Sloan Kettering Cancer Center, NY8 trials
8Suzanne GeorgeDana-Farber Cancer Institute, MA8 trials
9David ReardonDana-Farber Cancer Institute, MA7 trials
10Kristen GanjooStanford University School of Medicine, CA7 trials
11George DemetriDana-Farber Cancer Institute, MA7 trials
12Lee CranmerCity of Hope, CA7 trials
13Saroj Vadhan-RajTX6 trials
14Susan KrownMemorial Sloan Kettering Cancer Center, NY6 trials
15Brigitte WidemannMD6 trials
16Ramya RamaswamiNational Institutes of Health, MD6 trials
17Evanthia GalanisMayo Clinic, MN6 trials
18Crystal MackallStanford University School of Medicine, CA6 trials
19Richard GorlickThe University of Texas MD Anderson Cancer Center, TX6 trials
20Peter PistersThe University of Texas MD Anderson Cancer Center, TX6 trials
21Paul MeyersNY5 trials
22Hedy KindlerUniversity of Chicago, IL5 trials
23Scott OkunoMayo Clinic, MN5 trials
24Jana PortnowCity of Hope, CA5 trials
25Douglas HawkinsSeattle Children's Hospital, WA5 trials

Most cited

Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 88 of the 479 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.

#Expertcitations
1Thomas WalshCornell University, NY105,956 citations
2Patrick WenDana-Farber Cancer Institute89,244 citations
3Razelle KurzrockMedical College of Wisconsin, WI88,610 citations
4George DemetriDana-Farber Cancer Institute, MA64,250 citations
5David ReardonDana-Farber Cancer Institute, MA63,926 citations
6David HongThe University of Texas MD Anderson Cancer Center, TX47,734 citations
7Kathleen MooreUniversity of Nebraska Medical Center, OK47,487 citations
8Helen HeslopBaylor College of Medicine, TX43,332 citations
9Hedy KindlerUniversity of Chicago, IL39,455 citations
10Sumanta PalCity of Hope, CA34,788 citations
11Sarina Piha-PaulThe University of Texas MD Anderson Cancer Center, TX32,741 citations
12Jann SarkariaMayo Clinic, MN32,285 citations
13Vivek SubbiahStanford University School of Medicine, CA32,217 citations
14Alberto PappoSt. Jude Children's Research Hospital, TN31,860 citations
15Nilofer AzadJohns Hopkins University School of Medicine, MD30,922 citations
16Richard GorlickThe University of Texas MD Anderson Cancer Center, TX30,489 citations
17Alexander SpiraVirginia Cancer Specialists, VA29,600 citations
18James GulleyNational Cancer Institute, MD28,235 citations
19Evanthia GalanisMayo Clinic, MN27,798 citations
20Bayard PowellAtrium Health Wake Forest Baptist, NC27,638 citations
21Timothy YapThe University of Texas MD Anderson Cancer Center, TX27,287 citations
22Crystal MackallStanford University School of Medicine, CA26,440 citations
23William TapMemorial Sloan Kettering Cancer Center, NY25,942 citations
24Richard AmbinderJohns Hopkins University School of Medicine, MD25,685 citations
25Philip McCarthyRoswell Park Comprehensive Cancer Center, NY25,056 citations

Most NIH awards

NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 69 of the 479 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.

#Expertawards
1Lee RatnerMO26 awards
2Richard AmbinderJohns Hopkins University School of Medicine, MD19 awards
3Jann SarkariaMayo Clinic, MN19 awards
4David KirschNC15 awards
5Evanthia GalanisMayo Clinic, MN13 awards
6Timothy CripeOH12 awards
7Helen HeslopBaylor College of Medicine, TX9 awards
8David AshleyNC8 awards
9Crystal MackallStanford University School of Medicine, CA8 awards
10Kathleen MooreUniversity of Nebraska Medical Center, OK6 awards
11Hedy KindlerUniversity of Chicago, IL6 awards
12Nilofer AzadJohns Hopkins University School of Medicine, MD5 awards
13Scott SchuetzeUniversity of Michigan, MI5 awards
14Jana PortnowCity of Hope, CA5 awards
15Claire VerschraegenThe Ohio State University, OH5 awards
16Patrick WenDana-Farber Cancer Institute4 awards
17Joan WalkerUniversity of Oklahoma Health Sciences Center, OK4 awards
18Kim KramerMemorial Sloan Kettering Cancer Center, NY4 awards
19Zachary MorrisWI4 awards
20Kelly GoldsmithEmory University, GA4 awards
21Hui-Kuo ShuGA4 awards
22David HongThe University of Texas MD Anderson Cancer Center, TX4 awards
23Seth PollackNorthwestern University Feinberg School of Medicine, IL4 awards
24Howard FineNY3 awards
25Susan KrownMemorial Sloan Kettering Cancer Center, NY3 awards

Most congress contributions

Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 31 of the 479 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.

#Expertcontributions
1James GulleyNational Cancer Institute, MD255 contributions
2Timothy YapThe University of Texas MD Anderson Cancer Center, TX221 contributions
3Rita NandaUniversity of Chicago, IL196 contributions
4Hedy KindlerUniversity of Chicago, IL163 contributions
5Jonathan TrentUniversity of Miami Miller School of Medicine, FL148 contributions
6Richard GorlickThe University of Texas MD Anderson Cancer Center, TX140 contributions
7Steven DuboisDana-Farber Cancer Institute, MA126 contributions
8Nilofer AzadJohns Hopkins University School of Medicine, MD121 contributions
9Kevin CamphausenNational Cancer Institute (NCI), MD120 contributions
10Olatunji AleseEmory University, GA117 contributions
11Neeta SomaiahThe University of Texas MD Anderson Cancer Center, TX117 contributions
12Jann SarkariaMayo Clinic, MN108 contributions
13George DemetriDana-Farber Cancer Institute, MA105 contributions
14Douglas HawkinsSeattle Children's Hospital, WA93 contributions
15Claire VerschraegenThe Ohio State University, OH90 contributions
16Amir JazaeriThe University of Texas MD Anderson Cancer Center, TX87 contributions
17Nadia LaackMayo Clinic, MN86 contributions
18Scott SchuetzeUniversity of Michigan, MI82 contributions
19Alberto PappoSt. Jude Children's Research Hospital, TN78 contributions
20Rebecca ArendUniversity of Alabama at Birmingham, AL75 contributions
21Lee CranmerCity of Hope, CA68 contributions
22Alberto ChiapporiMoffitt Cancer Center, FL67 contributions
23Crystal MackallStanford University School of Medicine, CA66 contributions
24Andrew BrohlMoffitt Cancer Center, FL64 contributions
25Martee HensleyMemorial Sloan Kettering Cancer Center, NY60 contributions

Emerging

26 of the 479 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.

Nabil AhmedHouston Methodist, TX
Kayleen BaileyNY
Frank BalisChildren's Hospital of Philadelphia, PA
Jeremy ConnorsThe University of Texas MD Anderson Cancer Center, TX
Bruce DezubeXilio Therapeutics, MA
Sara FedericoSt. Jude Children's Research Hospital, TN
Charles ForscherCedars-Sinai Medical Center, CA
Douglas HawkinsSeattle Children's Hospital, WA
Meenakshi HegdeHouston Methodist, TX
Brian KaderaUniversity of California, Los Angeles, CA
Anusha KalbasiUniversity of California, Los Angeles, CA
Udai KammulaUniversity of Pittsburgh, PA
Jaffar KhanEmory University, GA
Nicolas LlosaJohns Hopkins University School of Medicine, MD
Yael MosseChildren's Hospital of Philadelphia, PA
Yvonne MoweryUniversity of Pittsburgh, PA
Shoba NavaiBaylor College of Medicine, TX
Theodore NowickiUniversity of California, Los Angeles, CA
Bilal OmerBaylor College of Medicine, TX
Alberto PappoSt. Jude Children's Research Hospital, TN
Michael PishvaianJohns Hopkins University School of Medicine, DC
Jack SingerWA
Stephen SkapekDuke University, NC
Corinne SummersSeattle Children's Hospital, WA
Jason YusteinEmory University, GA

How these tables are computed

The cohort is every profile in the directory tagged to Sarcoma, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.

Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.

The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.

What is deliberately absent

Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.

Filter, sort and open every Sarcoma profile in the directory